Brief: SSY Group Obtained Approvals From NMPA
13/08/2024 09:55
Aug 13 (Reuters) - SSY Group Ltd 2005.HK :
* OBTAINED APPROVALS FOR DRUG PRODUCTION AND REGISTRATION
FOR
SODIUM POTASSIUM MAGNESIUM AND CALCIUM CONCENTRATED SOLUTION
FROM NMPA
* OBTAINED APPROVALS FOR DRUG PRODUCTION AND REGISTRATION
FOR
LEVODOPA AND BENSERAZIDE HYDROCHLORIDE TABLETS FROM NMPA
Further company coverage: 2005.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth